OCC 3.90% 37.0¢ orthocell limited

Stem Cell Therapy advancements, page-468

  1. 268 Posts.
    lightbulb Created with Sketch. 23
    My understanding is that Remplir and Striate can be manufactured and kept “on the shelf” to some extent. Much easier to distribute. ATI/ACI are totally custom made to order products once decision made to use. For ATI, I was told the actual tendon biopsy can sit around waiting for the decision to produce the tenocytes but once made all systems are go. My surgeon was to do my implantation but had to go overseas urgently but he was able to find a radiologist who was familiar with the implantation.
    My take is that for doing ATI/ACI only, OCC would license a suitable lab in Europe and/or North America to do it as there is also an established distribution infrastructure there for time critical medical products.


 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.015(3.90%)
Mkt cap ! $77.54M
Open High Low Value Volume
38.5¢ 38.8¢ 37.0¢ $47.36K 125.2K

Buyers (Bids)

No. Vol. Price($)
4 77604 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 17571 3
View Market Depth
Last trade - 16.10pm 12/08/2024 (20 minute delay) ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.